| 1 |
34520744 | Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter. | 2022 Mar 17 |
1 |
| 2 |
34806438 | Brief Report: A Novel Sodium/Iodide Symporter Mutation, S356F, Causing Congenital Hypothyroidism. | 2022 Feb |
2 |
| 3 |
34922208 | Small activating RNA-activated NIS gene promotes 131I uptake and inhibits thyroid cancer via AMPK/mTOR pathway. | 2022 Jan |
7 |
| 4 |
35438852 | Clinical characteristics and genetics analysis for the ITD of congenital hypothyroidism. | 2022 Jun 27 |
2 |
| 5 |
35600585 | Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism. | 2022 |
1 |
| 6 |
33002449 | Expression of the sodium iodide symporter (NIS) in reproductive and neural tissues of teleost fish. | 2021 Jan 1 |
2 |
| 7 |
33779310 | The Iodide Transport Defect-Causing Y348D Mutation in the Na+/I- Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane. | 2021 Aug |
1 |
| 8 |
33912899 | A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis. | 2021 Jun 16 |
2 |
| 9 |
33974556 | Na+/I- symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy. | 2021 Sep 3 |
2 |
| 10 |
34196428 | The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane. | 2021 Aug |
4 |
| 11 |
34387194 | The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues. | 2021 Sep 3 |
4 |
| 12 |
34514854 | Impact of the Mutational Landscape of the Sodium/Iodide Symporter in Congenital Hypothyroidism. | 2021 Dec |
2 |
| 13 |
34771624 | Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer. | 2021 Oct 30 |
1 |
| 14 |
32049985 | TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells. | 2020 |
4 |
| 15 |
32084174 | Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS). | 2020 |
1 |
| 16 |
33055303 | Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease. | 2020 Dec |
1 |
| 17 |
33291224 | Species D Adenoviruses as Oncolytic Viral Vectors. | 2020 Dec 6 |
1 |
| 18 |
30191346 | Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer. | 2019 May |
1 |
| 19 |
31115276 | Novel Sodium/Iodide Symporter Compound Heterozygous Pathogenic Variants Causing Dyshormonogenic Congenital Hypothyroidism. | 2019 Jul |
1 |
| 20 |
31533238 | Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies. | 2019 Sep 17 |
1 |
| 21 |
29242405 | Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer. | 2018 May |
1 |
| 22 |
29467904 | Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I. | 2018 Mar |
1 |
| 23 |
29631680 | An investigation of NIS expression in gastric tissue of obese individuals. | 2018 Mar 31 |
2 |
| 24 |
30217930 | A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling. | 2018 Nov 1 |
2 |
| 25 |
30595693 | The Role of the NIS (SLC5A5) Gene in Papillary Thyroid Cancer: A Systematic Review. | 2018 |
3 |
| 26 |
28117294 | The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation. | 2017 Feb 9 |
2 |
| 27 |
28192058 | The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications. | 2017 Feb 10 |
2 |
| 28 |
28974598 | Molecular radiotheragnostics in thyroid disease. | 2017 Oct |
1 |
| 29 |
31966449 | Targeting of pertechnetate imaging of HepG2 hepatocellular carcinoma through the transduction of the survivin promoter controls the sodium iodide symporter. | 2017 |
1 |
| 30 |
27614840 | Sterol regulatory element-binding proteins are regulators of the sodium/iodide symporter in mammary epithelial cells. | 2016 Nov |
1 |
| 31 |
28036366 | Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging. | 2016 |
1 |
| 32 |
25410753 | Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy. | 2015 Jan |
1 |
| 33 |
25615643 | Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene. | 2015 |
1 |
| 34 |
26204134 | Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency. | 2015 Oct |
2 |
| 35 |
26282166 | The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis. | 2015 Oct 1 |
2 |
| 36 |
26599396 | Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake. | 2015 |
1 |
| 37 |
23988430 | The sodium/iodide symporter: state of the art of its molecular characterization. | 2014 Jan |
2 |
| 38 |
24369144 | Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter. | 2014 Jan-Feb |
3 |
| 39 |
24708099 | NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. | 2014 Jul |
2 |
| 40 |
24884806 | Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. | 2014 Apr 30 |
1 |
| 41 |
24888603 | Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter. | 2014 Jun 3 |
1 |
| 42 |
25309780 | Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. | 2014 Sep |
1 |
| 43 |
23117572 | Sodium/iodide symporter is expressed in the majority of seminomas and embryonal testicular carcinomas. | 2013 Feb |
2 |
| 44 |
23404856 | MEK inhibition leads to lysosome-mediated Na+/I- symporter protein degradation in human breast cancer cells. | 2013 Apr |
2 |
| 45 |
23420532 | The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma. | 2013 Feb |
2 |
| 46 |
23441638 | Modulation of sodium/iodide symporter expression in the salivary gland. | 2013 Aug |
1 |
| 47 |
23471296 | TRPM7 is regulated by halides through its kinase domain. | 2013 Aug |
2 |
| 48 |
23857380 | Na+/I- symporter and type 3 iodothyronine deiodinase gene expression in amniotic membrane and placenta and its relationship to maternal thyroid hormones. | 2013 Sep |
1 |
| 49 |
24052075 | The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells. | 2013 Sep 19 |
2 |
| 50 |
24193032 | EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene. | 2013 Nov 5 |
1 |